6.54
price down icon2.32%   -0.15
after-market Handel nachbörslich: 6.54
loading
Schlusskurs vom Vortag:
$6.69
Offen:
$6.69
24-Stunden-Volumen:
3.36M
Relative Volume:
1.44
Marktkapitalisierung:
$652.19M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-17.96
EPS:
-0.3641
Netto-Cashflow:
$-24.91M
1W Leistung:
+12.67%
1M Leistung:
+33.91%
6M Leistung:
+170.04%
1J Leistung:
+39.04%
1-Tages-Spanne:
Value
$6.395
$6.73
1-Wochen-Bereich:
Value
$5.78
$6.865
52-Wochen-Spanne:
Value
$2.12
$6.865

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Firmenname
Aquestive Therapeutics Inc
Name
Telefon
908-941-1900
Name
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Mitarbeiter
142
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
AQST's Discussions on Twitter

Vergleichen Sie AQST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
6.54 809.31M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.09 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.72 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
439.99 20.14B 3.08B 1.24B 1.07B 25.61

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt Oppenheimer Outperform
2024-12-17 Eingeleitet Cantor Fitzgerald Overweight
2024-05-10 Eingeleitet Leerink Partners Outperform
2024-04-11 Eingeleitet Piper Sandler Overweight
2024-03-28 Eingeleitet Raymond James Outperform
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2019-04-22 Eingeleitet H.C. Wainwright Buy
2019-01-03 Eingeleitet Lake Street Buy
2018-08-20 Eingeleitet JMP Securities Mkt Outperform
2018-08-20 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten

pulisher
08:59 AM

Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance

08:59 AM
pulisher
06:17 AM

Is Aquestive Therapeutics Inc. reversing from oversold territoryJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com

06:17 AM
pulisher
02:56 AM

How to build a dashboard for Aquestive Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - newser.com

02:56 AM
pulisher
Oct 09, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

JMP Securities Maintains Aquestive Therapeutics (AQST) Market Outperform Recommendation - Nasdaq

Oct 09, 2025
pulisher
Oct 09, 2025

What high frequency data says about Aquestive Therapeutics Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Obtains 2 New US Patents for Anaphylm Sublingual Film - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive receives two new patents for oral anaphylaxis treatment By Investing.com - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive receives two new patents for oral anaphylaxis treatment - Investing.com India

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire Inc.

Oct 08, 2025
pulisher
Oct 06, 2025

Signal strength of Aquestive Therapeutics Inc. stock in tech scanners2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Aquestive Therapeutics Inc. stock is seen as undervaluedWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Custom watchlist performance reports with Aquestive Therapeutics Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Statistical indicators supporting Aquestive Therapeutics Inc.’s strengthTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Advanced analytics toolkit walkthrough for Aquestive Therapeutics Inc.Portfolio Profit Report & AI Forecast for Swing Trade Picks - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

Aquestive Therapeutics Advances Anaphylm Clinical Development - TipRanks

Oct 01, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics SVP sells $63,000 in shares By Investing.com - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics CEO Barber sells $551k in shares By Investing.com - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics (NASDAQ:AQST) CEO Sells $550,798.29 in Stock - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Peter Boyd Sells 10,000 Shares of Aquestive Therapeutics (NASDAQ:AQST) Stock - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics (NASDAQ:AQST) Trading Down 5.3% After Insider Selling - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics SVP sells $63,000 in shares - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics Hits New 52-Week High of $6.00, Up 105.43% - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

What drives Aquestive Therapeutics Inc stock priceAI-Driven Market Analysis & Master Stock Selection - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics Hits New 52-Week High of $6.43 - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

Is Aquestive Therapeutics Inc a good long term investmentSmall Cap Stock Opportunities & Collaborate and Win Together - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Aquestive Therapeutics Inc stockVolume Weighted Average Price & See Risk Factors Before Making Any Move - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Published on: 2025-09-28 19:22:53 - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Aquestive Therapeutics Sees Stock Surge Following FDA Approval News - timothysykes.com

Sep 28, 2025
pulisher
Sep 27, 2025

AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - MSN

Sep 27, 2025

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aquestive Therapeutics Inc-Aktie (AQST) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Boyd Peter E.
See Remarks
Sep 26 '25
Sale
6.30
10,000
63,000
278,323
$19.77
price down icon 1.54%
$9.735
price down icon 2.50%
$53.95
price down icon 7.18%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.16%
$136.70
price down icon 1.40%
$439.99
price down icon 1.35%
Kapitalisierung:     |  Volumen (24h):